BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1609216)

  • 1. [Renal cell cancer: oncogenes and tumor suppressor genes].
    Dietrich PY; Droz JP
    Rev Prat; 1992 May; 42(10):1236-40. PubMed ID: 1609216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma.
    Anglard P; Tory K; Brauch H; Weiss GH; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1991 Feb; 51(4):1071-7. PubMed ID: 1671754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor suppressor genes associated with development of human renal cell carcinoma].
    Morita R; Hikiji K; Yamakawa K; Nakamura Y
    Nihon Rinsho; 1992 Dec; 50(12):3100-5. PubMed ID: 1491460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A detailed deletion mapping of the short arm of chromosome 3 in sporadic renal cell carcinoma.
    Yamakawa K; Morita R; Takahashi E; Hori T; Ishikawa J; Nakamura Y
    Cancer Res; 1991 Sep; 51(17):4707-11. PubMed ID: 1678685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic studies of sporadic and familial renal cell carcinoma.
    Gnarra JR; Glenn GM; Latif F; Anglard P; Lerman MI; Zbar B; Linehan WM
    Urol Clin North Am; 1993 May; 20(2):207-16. PubMed ID: 8098558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis of renal cell cancer.
    Linehan WM; Gnarra JR; Lerman MI; Latif F; Zbar B
    Important Adv Oncol; 1993; ():47-70. PubMed ID: 8505056
    [No Abstract]   [Full Text] [Related]  

  • 8. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas.
    Cairns P; Tokino K; Eby Y; Sidransky D
    Cancer Res; 1995 Jan; 55(2):224-7. PubMed ID: 7812948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
    Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
    Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and cellular characterization of human renal cell carcinoma cell lines.
    Anglard P; Trahan E; Liu S; Latif F; Merino MJ; Lerman MI; Zbar B; Linehan WM
    Cancer Res; 1992 Jan; 52(2):348-56. PubMed ID: 1345811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nakahara memorial lecture. Hereditary cancer, oncogenes, and anti-oncogenes.
    Knudson AG
    Princess Takamatsu Symp; 1989; 20():15-29. PubMed ID: 2577335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
    Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
    Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cell carcinoma. Molecular genetics and clinical implications.
    Jennings SB; Gnarra JR; Walther MM; Zbar B; Linehan WM
    Surg Oncol Clin N Am; 1995 Apr; 4(2):219-29. PubMed ID: 7796282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas.
    Shuin T; Kondo K; Torigoe S; Kishida T; Kubota Y; Hosaka M; Nagashima Y; Kitamura H; Latif F; Zbar B
    Cancer Res; 1994 Jun; 54(11):2852-5. PubMed ID: 8187067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequently deleted loci on chromosome 9 may harbor several tumor suppressor genes in human renal cell carcinoma.
    Grady B; Goharderakhshan R; Chang J; Ribeiro-Filho LA; Perinchery G; Franks J; Presti J; Carroll P; Dahiya R
    J Urol; 2001 Sep; 166(3):1088-92. PubMed ID: 11490304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic organization and chromosomal localization of the human CUL2 gene and the role of von Hippel-Lindau tumor suppressor-binding protein (CUL2 and VBP1) mutation and loss in renal-cell carcinoma development.
    Clifford SC; Walsh S; Hewson K; Green EK; Brinke A; Green PM; Gianelli F; Eng C; Maher ER
    Genes Chromosomes Cancer; 1999 Sep; 26(1):20-8. PubMed ID: 10441001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning of a new familial t(3;8) translocation associated with conventional renal cell carcinoma reveals a 5 kb microdeletion and no gene involved in the rearrangement.
    Rodríguez-Perales S; Meléndez B; Gribble SM; Valle L; Carter NP; Santamaría I; Conde L; Urioste M; Benítez J; Cigudosa JC
    Hum Mol Genet; 2004 May; 13(9):983-90. PubMed ID: 15016767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics of renal tumors].
    Oláh E; Jakab Z; Balogh E
    Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent deletion of the short arm of chromosome 3 in human renal cell carcinoma: shift of the c-raf 1 locus.
    Teyssier JR; Henry I; Dozier C; Ferre D; Adnet JJ; Pluot M
    J Natl Cancer Inst; 1986 Dec; 77(6):1187-95. PubMed ID: 3467112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 17p deletions and p53 mutations in renal cell carcinoma.
    Reiter RE; Anglard P; Liu S; Gnarra JR; Linehan WM
    Cancer Res; 1993 Jul; 53(13):3092-7. PubMed ID: 8319216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.